Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShare-based Compensation (IS)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

IM Cannabis (IMCC) EBIT: 2019-2025

Historic EBIT for IM Cannabis (IMCC) over the last 6 years, with Sep 2025 value amounting to -$3.0 million.

  • IM Cannabis' EBIT fell 331.86% to -$3.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $870,777, marking a year-over-year increase of 103.96%. This contributed to the annual value of -$7.5 million for FY2024, which is 21.16% up from last year.
  • As of Q3 2025, IM Cannabis' EBIT stood at -$3.0 million, which was down 1,094.37% from -$252,599 recorded in Q2 2025.
  • IM Cannabis' EBIT's 5-year high stood at $7.0 million during Q1 2022, with a 5-year trough of -$37.5 million in Q4 2022.
  • Moreover, its 3-year median value for EBIT was -$252,599 (2025), whereas its average is -$1.4 million.
  • Its EBIT has fluctuated over the past 5 years, first crashed by 1,181.70% in 2021, then soared by 619.24% in 2022.
  • Quarterly analysis of 5 years shows IM Cannabis' EBIT stood at -$6.9 million in 2021, then tumbled by 440.46% to -$37.5 million in 2022, then skyrocketed by 59.98% to -$15.0 million in 2023, then soared by 126.87% to $4.0 million in 2024, then plummeted by 331.86% to -$3.0 million in 2025.
  • Its EBIT stands at -$3.0 million for Q3 2025, versus -$252,599 for Q2 2025 and $110,113 for Q1 2025.